Koninklijke Philips Cash Flow from Operating Activities 2010-2023 | PHG
Koninklijke Philips annual/quarterly cash flow from operating activities history and growth rate from 2010 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Koninklijke Philips cash flow from operating activities for the quarter ending September 30, 2023 was $0.367B, a 52.39% decline year-over-year.
- Koninklijke Philips cash flow from operating activities for the twelve months ending September 30, 2023 was $0.587B, a 69.14% decline year-over-year.
- Koninklijke Philips annual cash flow from operating activities for 2023 was $2.312B, a 1368.31% decline from 2022.
- Koninklijke Philips annual cash flow from operating activities for 2022 was $-0.182B, a 109.46% decline from 2021.
- Koninklijke Philips annual cash flow from operating activities for 2021 was $1.927B, a 39.24% decline from 2020.
| Koninklijke Philips Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2023 | $2,312 |
| 2022 | $-182 |
| 2021 | $1,927 |
| 2020 | $3,172 |
| 2019 | $2,275 |
| 2018 | $2,102 |
| 2017 | $2,114 |
| 2016 | $2,107 |
| 2015 | $1,296 |
| 2014 | $1,732 |
| 2013 | $1,512 |
| 2012 | $2,827 |
| 2011 | $1,164 |
| 2010 | $2,863 |
| 2009 | $2,155 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $25.408B | $19.663B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.990B | 23.17 |
| Stryker (SYK) | United States | $129.721B | 31.07 |
| Boston Scientific (BSX) | United States | $110.032B | 35.05 |
| Medtronic (MDT) | Ireland | $107.023B | 15.47 |
| EssilorLuxottica (ESLOY) | France | $100.473B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.064B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.264B | 27.93 |
| ResMed (RMD) | United States | $30.754B | 28.87 |
| Terumo (TRUMY) | Japan | $25.118B | 35.47 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.544B | 15.04 |
| Baxter (BAX) | United States | $17.035B | 12.11 |
| Insulet (PODD) | United States | $12.323B | 54.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.938B | 0.00 |
| Demant (WILYY) | Denmark | $10.259B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.044B | 26.31 |
| BellRing Brands (BRBR) | United States | $7.479B | 35.18 |
| Lantheus Holdings (LNTH) | United States | $5.581B | 13.91 |
| GN Store Nord (GNNDY) | Denmark | $4.717B | 26.49 |
| Haemonetics (HAE) | United States | $4.304B | 21.27 |
| Perrigo (PRGO) | Ireland | $3.758B | 11.39 |
| Envista Holdings (NVST) | United States | $3.245B | 13.39 |
| Prestige Consumer Healthcare (PBH) | United States | $3.135B | 14.92 |
| QuidelOrtho (QDEL) | United States | $2.960B | 16.43 |
| Neogen (NEOG) | United States | $2.857B | 27.48 |
| TG Therapeutics (TGTX) | United States | $2.610B | 73.43 |
| ICU Medical (ICUI) | United States | $2.523B | 22.26 |
| Green Thumb Industries (GTBIF) | United States | $2.367B | 46.88 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.240B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.131B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.768B | 51.82 |
| Warby Parker (WRBY) | United States | $1.729B | 0.00 |
| InMode (INMD) | Israel | $1.585B | 8.42 |
| Verano Holdings (VRNOF) | United States | $1.463B | 0.00 |
| Owens & Minor (OMI) | United States | $1.320B | 11.50 |
| AdaptHealth (AHCO) | United States | $1.291B | 9.59 |
| National Vision Holdings (EYE) | United States | $1.150B | 36.60 |
| AtriCure (ATRC) | United States | $1.059B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.001B | 0.00 |
| Evolus (EOLS) | United States | $0.789B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.721B | 15.35 |
| Canopy Growth (CGC) | Canada | $0.655B | 0.00 |
| Quanterix (QTRX) | United States | $0.625B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.624B | 0.00 |
| Valneva SE (VALN) | France | $0.620B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.619B | 14.56 |
| PetIQ (PETQ) | United States | $0.612B | 19.78 |
| Surmodics (SRDX) | United States | $0.600B | 37.59 |
| ZimVie (ZIMV) | United States | $0.452B | 38.49 |
| TerrAscend (TSNDF) | Canada | $0.449B | 0.00 |
| Jin Medical (ZJYL) | China | $0.425B | 0.00 |
| Biote (BTMD) | United States | $0.407B | 9.37 |
| OraSure Technologies (OSUR) | United States | $0.348B | 11.19 |
| Cerus (CERS) | United States | $0.338B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.335B | 0.00 |
| Zynex (ZYXI) | United States | $0.315B | 43.13 |
| Viemed Healthcare (VMD) | United States | $0.280B | 27.69 |
| MacroGenics (MGNX) | United States | $0.266B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.260B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.252B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.237B | 14.92 |
| TriSalus Life Sciences (TLSI) | United States | $0.202B | 0.00 |
| High Tide (HITI) | Canada | $0.197B | 0.00 |
| Omeros (OMER) | United States | $0.192B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.177B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.156B | 75.00 |
| Quipt Home Medical (QIPT) | United States | $0.146B | 0.00 |
| Veru (VERU) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.141B | 19.98 |
| InterCure (INCR) | Israel | $0.134B | 22.61 |
| Jushi Holdings (JUSHF) | United States | $0.119B | 0.00 |
| Brainsway (BWAY) | Israel | $0.109B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.109B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 8.46 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.086B | 0.00 |
| MariMed (MRMD) | United States | $0.081B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.072B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.044B | 2.90 |
| United-Guardian (UG) | United States | $0.043B | 15.45 |
| Bright Green (BGXX) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| ImmuCell (ICCC) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| Innovative Eyewear (LUCY) | United States | $0.019B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |